Mission Bio Pharma Assay Development Services

Mission Bio has launched its Pharma Assay Development (PAD) services to help biopharma customers accelerate biomarker discovery and cell and gene therapy development. The PAD team will provide customers with services based on Mission Bio's existing single-cell multiomics technologies, as well as early access to services based on new technology innovations, the company said.